Breaking News Instant updates and real-time market news.

USIO

Usio

$2.43 /

+0.06 (+2.53%)

09:06
07/05/22
07/05
09:06
07/05/22
09:06

Usio CEO provides letter to shareholders

The letter said, "Usio is a company that serves various industries with diverse payment channels so our customers can collect and issue payments. This has served us well during both good and poor economic conditions. In 2020, unlike other companies in the payment space, we grew revenue as compared to 2019 because of this diversity. As one payment channel or industry was negatively impacted by the Covid shutdown, another payment channel or industry was positively impacted. The economy continues to be volatile in many areas and as we navigate these changes, we are experiencing a positive trend with certain client segments and more uncertain trends that we are watching closely, both of which I want to comment on. First, our non-bank lending segment has increased the volume of ACH transactions due to the growth in consumers loans, which naturally leads to more ACH repayments. The growth in consumer loans is also leading to an increase in returned check transactions. Returned checks are the highest margin sub-business of our ACH offering, with gross margins exceeding 80%. In the month of June, we processed more returned check transactions than we have in any month over the last eleven years. We expect to report both sequential and year over year growth in ACH returned check processing for the second quarter of 2022. Additionally, we expect to report sequential growth in total ACH transactions processed. However, as previously communicated, in the second quarter of 2022 we expect to report a year-over-year decline in the number of ACH transactions processed because this quarter will be compared to the record volume of the year ago quarter that was caused by the explosion in crypto enthusiasm. We were pleased to report that we expect the decline to be mild and the resulting revenues for ACH similar to Q2 of 2021. Second, on July 1, 2022, we became aware that one of our partners, Voyager Digital, publicly announced their intent to, "...temporarily suspending trading, deposits, withdrawals, and loyalty rewards effective at 2:00 p.m. Eastern Daylight Time today [July 1, 2022]." Usio has provided, and continues to provide, payment processing services for Voyager, and both our ACH and prepaid services for Voyager are fully available to them. We expect to continue processing transactions as requested by Voyager. However, as a result of Voyager's announcement, we believe the ACH volume of transactions we process for Voyager, and consequently our revenues, will be adversely impacted unless Voyager resumes full operations. Voyager is independent from Usio and we can't predict when, or if, Voyager will resume operations in any capacity. Voyager represented 8% of Usio's total revenue for full year 2021 and 8% of Usio's revenues from January 1, 2022 through May 31, 2022. Of the 8% of revenue generated from Voyager in 2022, 2% represented revenue derived from blank card orders for Voyager's prepaid card program, on which Usio earned no margin because we sold those cards to Voyager at cost in anticipation of future transactional revenue from card holder usage. Usio's fiscal 2022 guidance assumed only $1 million in revenue derived from Voyager's prepaid card program services for 2022. Through May 31, 2022, revenues from the prepaid card services were approximately $670,000. Thus, we expect the impact of a slowdown or end to this prepaid card program on our bottom line to be minimal. Voyager's accounts receivable balances with Usio are minimal as of July 5, 2022. Because of the strength of our new sales pipeline, potential spoilage on cards and the trends we are seeing in our non-bank lenders, we believe we will be able to replace any potential revenue shortfall from the suspended Voyager processing anticipated in our guidance. Consequently, Usio is reiterating its fiscal 2022 revenue guidance, but widening the range to 16-20% revenue growth for 2022 over 2021. As always, the revenue guidance is conditioned on favorable economic conditions. We expect the revenue replacement to be comprised of new PayFac relationships that will carry a lower margin than the margins we expected to earn on ACH transaction processing. We also have over $15 million in potential card spoilage revenue that we expect to start to recognize in September of this year and continue to recognize for the following 12-18 months. Spoilage carries significant margins that can be up to 50-80%. We believe Voyager's announcement is a temporary distraction from our rapid growth, and we expect to manage these challenges and achieve our objectives for the year consistent with our recent track record. We have initiated our share buyback plan which was previously announced and have already purchased over $400,000 of Usio stock in the open market. Finally, Usio is well positioned to capitalize on further growth opportunities leveraging our strong balance sheet with a sufficient cash balance ($7.6 Million as of March 30, 2022) and less than $115,000 in debt. I look forward to ending the year with strong growth from our PayFac and prepaid segments, and Output Solutions outperforming our expectations."

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Jack Henry to acquire PayRailz, terms not disclosed » 11:02
08/09/22
08/09
11:02
08/09/22
11:02
JKHY

Jack Henry

$210.85 /

-0.2 (-0.09%)

Jack Henry &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JKHY Jack Henry
$210.85 /

-0.2 (-0.09%)

JKHY Jack Henry
$210.85 /

-0.2 (-0.09%)

07/25/22 Oppenheimer
Jack Henry price target lowered to $214 from $220 at Oppenheimer
06/15/22 Morgan Stanley
Jack Henry initiated with an Equal Weight at Morgan Stanley
03/01/22 Oppenheimer
Jack Henry upgraded to Outperform from Perform at Oppenheimer
02/11/22 DA Davidson
Jack Henry price target raised to $204 from $188 at DA Davidson
JKHY Jack Henry
$210.85 /

-0.2 (-0.09%)

JKHY Jack Henry
$210.85 /

-0.2 (-0.09%)

Options
Size spread in ChargePoint adjusts large position reset yesterday » 11:00
08/09/22
08/09
11:00
08/09/22
11:00
CHPT

ChargePoint

$15.45 /

-0.53 (-3.32%)

Size spread in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

07/18/22 Fox Advisors
ChargePoint upgraded to Overweight from Equal Weight at Fox Advisors
07/14/22 JPMorgan
ChargePoint risk/reward attractive for long-term investors, says JPMorgan
06/22/22 Stifel
ChargePoint price target lowered to $26 from $32 at Stifel
06/17/22 B. Riley
ChargePoint initiated with Buy on 'dominant' market share at B. Riley
CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

Conference/Events
JPMorgan private markets analysts hold analyst/industry conference call » 10:59
08/09/22
08/09
10:59
08/09/22
10:59

Global Head of Private…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Kohl's put volume heavy and directionally bearish » 10:55
08/09/22
08/09
10:55
08/09/22
10:55
KSS

Kohl's

$30.22 /

-1.23 (-3.91%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KSS Kohl's
$30.22 /

-1.23 (-3.91%)

KSS Kohl's
$30.22 /

-1.23 (-3.91%)

08/04/22 Cowen
Kohl's downgraded to Market Perform on consumer pressure at Cowen
08/04/22 Cowen
Kohl's downgraded to Market Perform from Outperform at Cowen
07/26/22 Deutsche Bank
Walmart outlook 'red flag for apparel,' says Deutsche Bank
07/15/22 UBS
Kohl's price target lowered to $20 from $32 at UBS
KSS Kohl's
$30.22 /

-1.23 (-3.91%)

KSS Kohl's
$30.22 /

-1.23 (-3.91%)

KSS Kohl's
$30.22 /

-1.23 (-3.91%)

KSS Kohl's
$30.22 /

-1.23 (-3.91%)

Hot Stocks
WeTrade Group Inc trading resumes  10:54
08/09/22
08/09
10:54
08/09/22
10:54
WETG

WeTrade

$17.20 /

-1 (-5.49%)

 
ShowHide Related Items >><<
WETG WeTrade
$17.20 /

-1 (-5.49%)

  • 19
    Jul
Initiation
Holley initiated with an Outperform at Imperial Capital » 10:51
08/09/22
08/09
10:51
08/09/22
10:51
HLLY

Holley

$5.99 /

-0.22 (-3.54%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLLY Holley
$5.99 /

-0.22 (-3.54%)

HLLY Holley
$5.99 /

-0.22 (-3.54%)

07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
07/29/22 JPMorgan
Holley downgraded to Neutral from Overweight at JPMorgan
07/29/22 Jefferies
Holley downgraded to Hold from Buy at Jefferies
06/28/22 JPMorgan
Holley initiated with an Overweight at JPMorgan
HLLY Holley
$5.99 /

-0.22 (-3.54%)

  • 21
    Apr
HLLY Holley
$5.99 /

-0.22 (-3.54%)

General news
Wall Street is turning lower » 10:50
08/09/22
08/09
10:50
08/09/22
10:50
$ECON

Economic Data

/

+

Wall Street is turning…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Initiation
Hygeia Healthcare initiated with a Neutral at Goldman Sachs » 10:47
08/09/22
08/09
10:47
08/09/22
10:47
HYHHF

Hygeia Healthcare

/

+

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Peabody Energy call volume above normal and directionally bullish » 10:45
08/09/22
08/09
10:45
08/09/22
10:45
BTU

Peabody Energy

$20.61 /

+1.425 (+7.43%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

07/07/22 B. Riley
Peabody Energy price target lowered to $33 from $34 at B. Riley
06/07/22 Jefferies
Peabody Energy upgraded to Buy from Hold at Jefferies
05/02/22 B. Riley
Peabody Energy price target raised to $34 from $32 at B. Riley
05/02/22 Benchmark
Peabody Energy price target raised to $29 from $19 at Benchmark
BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

Hot Stocks
GoodRx rallies after saying grocer issue recently addressed » 10:44
08/09/22
08/09
10:44
08/09/22
10:44
GDRX

GoodRx

$8.13 /

+0.35 (+4.50%)

GoodRx said in last…

GoodRx said in last night's earnings letter, "We are pleased to share that the grocer issue we discussed on our first quarter earnings call was very recently addressed. As communication is rolled out to the grocery chain's pharmacists, we expect GoodRx discounts to be consistently welcomed at the point of sale. We are delighted that our consumers can enjoy the prescription access and affordability benefits of GoodRx at the grocery chain, who we value as a partner. Despite this very recent positive development, we do not anticipate a meaningful volume or revenue lift in the third quarter based on the rollout timeline of relevant communications to the grocery chain's pharmacies, new user adoption and returning user levels. We expect third quarter revenue to be approximately $185 million. This assumes the grocer issue has an estimated impact of $35 million to $40 million on third quarter prescription transactions revenue. We're expecting a greater impact quarter-over-quarter because the effect on the second quarter gradually increased as the quarter developed, whereas we started the third quarter facing a significant impact. In addition to the effect of the grocer issue on prescription transactions revenue, we expect our recent consumer engagement efforts, which we will discuss on our second quarter earnings call, to negatively impact prescription transactions revenue by approximately $5 million in the third quarter." Shares of GoodRx are up 6% to $8.20 in morning trading.

ShowHide Related Items >><<
GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

10:40 Today Goldman Sachs
Goldman Sachs raises GoodRx price target to $10 amid grocer issue resolution
07:58 Today RBC Capital
GoodRx price target raised to $11 from $6.50 at RBC Capital
05:50 Today Barclays
GoodRx price target raised to $13 from $12 at Barclays
07/20/22 Barclays
GoodRx price target lowered to $12 from $15 at Barclays
GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

Hot Stocks
WeTrade Group Inc trading halted, volatility trading pause  10:44
08/09/22
08/09
10:44
08/09/22
10:44
WETG

WeTrade

$17.30 /

-0.9 (-4.95%)

 
ShowHide Related Items >><<
WETG WeTrade
$17.30 /

-0.9 (-4.95%)

  • 19
    Jul
Periodicals
Blue Owl Capital's Dyal in talks to buy stake in PAI Partners, Bloomberg says » 10:43
08/09/22
08/09
10:43
08/09/22
10:43
OWL

Blue Owl Capital

$12.52 /

+0.035 (+0.28%)

Blue Owl Capital's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

07/11/22 JPMorgan
Blue Owl Capital initiated with a Neutral at JPMorgan (Thursday)
06/08/22 JMP Securities
Blue Owl Capital initiated with an Outperform at JMP Securities
01/24/22 BofA
Blue Owl Capital initiated with a Buy at BofA
01/24/22 BofA
Blue Owl Capital initiated with a Buy at BofA
OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

  • 02
    Jun
  • 08
    Dec
OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

Recommendations
Goldman Sachs raises GoodRx price target to $10 amid grocer issue resolution » 10:40
08/09/22
08/09
10:40
08/09/22
10:40
GDRX

GoodRx

$8.28 /

+0.5 (+6.43%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

07:58 Today RBC Capital
GoodRx price target raised to $11 from $6.50 at RBC Capital
05:50 Today Barclays
GoodRx price target raised to $13 from $12 at Barclays
07/20/22 Barclays
GoodRx price target lowered to $12 from $15 at Barclays
07/18/22 Guggenheim
GoodRx price target lowered to $13 from $17 at Guggenheim
GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

Periodicals
Avaya taps Kirkland & Ellis to advise on options, WSJ reports » 10:37
08/09/22
08/09
10:37
08/09/22
10:37
AVYA

Avaya

/

+

Avaya has selected…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVYA Avaya
/

+

AVYA Avaya
/

+

07/29/22 Craig-Hallum
Avaya downgraded to Hold from Buy at Craig-Hallum
07/29/22 Craig-Hallum
Avaya downgraded to Hold from Buy at Craig-Hallum
07/26/22 Barclays
Avaya price target lowered to $2 from $5 at Barclays
06/06/22 Citi
Avaya price target lowered to $6 from $9 at Citi
AVYA Avaya
/

+

AVYA Avaya
/

+

AVYA Avaya
/

+

Options
Warner Bros Discovery Inc put volume heavy and directionally bearish » 10:35
08/09/22
08/09
10:35
08/09/22
10:35
WBD

Warner Bros. Discovery

$13.49 /

-0.52 (-3.71%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

08/08/22 Barrington
Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington
08/05/22 Wells Fargo
Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo
08/05/22 Barclays
Warner Bros. Discovery price target lowered to $17 from $19 at Barclays
08/04/22 Credit Suisse
Warner Bros. Discovery price target lowered to $43 from $52 at Credit Suisse
WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

General news
European Fixed Income Summary: » 10:35
08/09/22
08/09
10:35
08/09/22
10:35
$ECON

Economic Data

/

+

European Fixed Income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Downgrade
Canoo downgraded to Neutral at Roth Capital on increased need for cash » 10:31
08/09/22
08/09
10:31
08/09/22
10:31
GOEV

Canoo

$3.51 /

-0.445 (-11.27%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

10:28 Today Roth Capital
Canoo downgraded to Neutral from Buy at Roth Capital
08:41 Today R.F. Lafferty
Canoo price target lowered to $15 from $17 at R.F. Lafferty
07/14/22 R.F. Lafferty
Canoo price target lowered to $17 from $20 at R.F. Lafferty
07/13/22 H.C. Wainwright
Canoo price target lowered to $10 from $15 at H.C. Wainwright
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

Downgrade
Canoo downgraded to Neutral from Buy at Roth Capital » 10:28
08/09/22
08/09
10:28
08/09/22
10:28
GOEV

Canoo

$3.51 /

-0.445 (-11.27%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

08:41 Today R.F. Lafferty
Canoo price target lowered to $15 from $17 at R.F. Lafferty
07/14/22 R.F. Lafferty
Canoo price target lowered to $17 from $20 at R.F. Lafferty
07/13/22 H.C. Wainwright
Canoo price target lowered to $10 from $15 at H.C. Wainwright
12/16/21 R.F. Lafferty
Canoo price target raised to $21 from $19 at R.F. Lafferty
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

Hot Stocks
Verona Pharma surges after ensifentrine meets endpoint in COPD study » 10:28
08/09/22
08/09
10:28
08/09/22
10:28
VRNA

Verona Pharma

$12.69 /

+5.76 (+83.12%)

Verona Pharma shares are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

06/17/22 Wedbush
Verona Pharma price target lowered to $18 from $25 at Wedbush
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 H.C. Wainwright
Verona Pharma initiated with a Buy at H.C. Wainwright
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

Earnings
Sysco reaffirms FY24 adjusted EPS guidance 30% higher than FY19 » 10:27
08/09/22
08/09
10:27
08/09/22
10:27
SYY

Sysco

$85.16 /

-1.53 (-1.76%)

Previously provided FY24…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

06/29/22 Barclays
Sysco price target raised to $102 from $97 at Barclays
06/09/22 Barclays
Sysco price target lowered to $97 from $102 at Barclays
05/26/22 JPMorgan
Sysco upgraded to Overweight after recent pullback at JPMorgan
05/26/22 JPMorgan
Sysco upgraded to Overweight from Neutral at JPMorgan
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

Earnings
Verona Pharma reports Q2 EPS (4c), consensus (38c) » 10:27
08/09/22
08/09
10:27
08/09/22
10:27
VRNA

Verona Pharma

$12.69 /

+5.76 (+83.12%)

The company's cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

06/17/22 Wedbush
Verona Pharma price target lowered to $18 from $25 at Wedbush
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 H.C. Wainwright
Verona Pharma initiated with a Buy at H.C. Wainwright
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

Earnings
Sysco prepared to generate sales growth of at least 10% in 2023 » 10:27
08/09/22
08/09
10:27
08/09/22
10:27
SYY

Sysco

$85.16 /

-1.53 (-1.76%)

Food away from home is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

06/29/22 Barclays
Sysco price target raised to $102 from $97 at Barclays
06/09/22 Barclays
Sysco price target lowered to $97 from $102 at Barclays
05/26/22 JPMorgan
Sysco upgraded to Overweight after recent pullback at JPMorgan
05/26/22 JPMorgan
Sysco upgraded to Overweight from Neutral at JPMorgan
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

Hot Stocks
Liberty TripAdvisor Holdings trading resumes  10:27
08/09/22
08/09
10:27
08/09/22
10:27
 
Options
B. Riley Principal 150 Merger Corp call volume above normal and directionally bullish » 10:25
08/09/22
08/09
10:25
08/09/22
10:25
FAZE

FaZe Holdings

$14.69 /

+0.49 (+3.45%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FAZE FaZe Holdings
$14.69 /

+0.49 (+3.45%)

FAZE FaZe Holdings
$14.69 /

+0.49 (+3.45%)

General news
U.S. IBD/TIPP economic optimism index slipped to -0.4 ticks to 38.1 in August » 10:25
08/09/22
08/09
10:25
08/09/22
10:25
$ECON

Economic Data

/

+

U.S. IBD/TIPP economic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.